Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ELVN - Enliven Therapeutics, Inc.
234 M
LAST VALUE
1425.11%
2 YEAR CAGR
104.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR